Bayforest Capital Ltd Buys New Shares in Masimo Corporation $MASI

Bayforest Capital Ltd bought a new stake in shares of Masimo Corporation (NASDAQ:MASI) in the 2nd quarter, HoldingsChannel reports. The firm bought 6,705 shares of the medical equipment provider’s stock, valued at approximately $1,128,000. Masimo accounts for about 0.5% of Bayforest Capital Ltd’s holdings, making the stock its 20th largest position.

Several other institutional investors and hedge funds have also added to or reduced their stakes in MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after purchasing an additional 66 shares during the last quarter. Xponance Inc. increased its stake in shares of Masimo by 1.1% during the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider’s stock worth $1,183,000 after purchasing an additional 76 shares during the last quarter. Deutsche Bank AG increased its stake in shares of Masimo by 1.5% during the 1st quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider’s stock worth $1,051,000 after purchasing an additional 92 shares during the last quarter. State of Michigan Retirement System increased its stake in shares of Masimo by 1.0% during the 1st quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider’s stock worth $1,765,000 after purchasing an additional 100 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its stake in shares of Masimo by 0.8% during the 1st quarter. Louisiana State Employees Retirement System now owns 12,400 shares of the medical equipment provider’s stock worth $2,066,000 after purchasing an additional 100 shares during the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently issued reports on MASI. Piper Sandler upped their price objective on shares of Masimo from $200.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 6th. BTIG Research reaffirmed a “buy” rating and set a $198.00 price objective on shares of Masimo in a report on Thursday, September 11th. Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a report on Tuesday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Finally, Zacks Research raised shares of Masimo from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 3rd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $194.60.

Insiders Place Their Bets

In other Masimo news, Director William R. Jellison bought 3,000 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were acquired at an average price of $145.98 per share, with a total value of $437,940.00. Following the completion of the purchase, the director directly owned 4,790 shares in the company, valued at $699,244.20. The trade was a 167.60% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 16.90% of the stock is currently owned by insiders.

Masimo Stock Up 2.3%

MASI stock opened at $148.01 on Tuesday. Masimo Corporation has a twelve month low of $133.70 and a twelve month high of $194.88. The company has a market cap of $8.04 billion, a PE ratio of -17.37 and a beta of 1.28. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57. The business’s 50-day simple moving average is $145.76 and its 200 day simple moving average is $155.04.

Masimo (NASDAQ:MASI) last issued its earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share for the quarter. The business had revenue of $617.00 million for the quarter. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. On average, research analysts anticipate that Masimo Corporation will post 4.1 earnings per share for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.